Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/17/2025

Treatment of Complex Migraine

Introduction to Treatment

  • The American Academy of Neurology recommends a stepped care approach for complex migraine treatment, starting with NSAIDs as first-line therapy, progressing to triptans as second-line, and considering newer agents like ditans or gepants as third-line options, with careful attention to avoiding medications that may increase stroke risk 1, 2

Acute Treatment

  • NSAIDs are recommended as initial therapy for mild to moderate attacks, with options including ibuprofen 400-800 mg every 6 hours, naproxen sodium 275-550 mg every 2-6 hours, and aspirin 650-1000 mg every 4-6 hours 1, 2, 3
  • Combination analgesics containing caffeine may also be effective for acute treatment 3, 4
  • Triptans are recommended as second-line therapy for moderate to severe attacks, with most effective use when taken early in an attack while pain is still mild 1, 2
  • For patients who fail triptan therapy or have contraindications, ditans or gepants may be considered as third-line options 2

Adjunctive Therapy

  • For nausea and vomiting, metoclopramide or prochlorperazine may be used, and domperidone can be used as an oral antiemetic 1, 3

Important Cautions

  • Triptans should be used with caution in patients with risk factors for cardiovascular disease 1
  • Opioids and barbiturates should be avoided due to the risk of medication overuse headache, dependency, and limited evidence supporting their use 1, 3

Preventive Treatment

  • For patients with frequent complex migraines, first-line preventive options include topiramate and valproic acid, with topiramate being first-line for chronic migraine due to lower cost 5, 6
  • OnabotulinumtoxinA and CGRP monoclonal antibodies may be considered for patients who have failed other preventive medications 6

Managing Comorbidities

  • Comorbid conditions such as depression, sleep disturbances, obesity, and cardiovascular risk factors should be identified and treated, with consideration of medications like amitriptyline and topiramate 7

Monitoring and Follow-up

  • Patients should be educated about the risk of medication overuse headache and monitored for transformation to chronic migraine, especially in patients with risk factors 4, 5, 6